Michael Severino to step down as AbbVie Vice Chairman and President, effective May 31, 2022

AbbVie Inc.

Michael E. Severino will depart as Vice Chairman and President of AbbVie, effective May 31, 2022.
Severino is leaving to become CEO-Partner at a bioplatform innovation company and CEO of one of its portfolio companies.
No replacement has been announced for Severino's roles at AbbVie.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael E. Severino

Vice Chairman and President

ABBV · AbbVie Inc.

Effective: 2022-05-31
Filed: April 13, 2022, 7:59 PM ET

On April 8, 2022, Michael E Severino informed AbbVie that he will be departing as AbbVie’s Vice Chairman and President, effective May 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael E. Severino departed as Vice Chairman and President at AbbVie Inc..

Action: departing
Role: Vice Chairman and President

Exact text from the filing

On April 8, 2022, Michael E Severino informed AbbVie that he will be departing as AbbVie’s Vice Chairman and President, effective May 31, 2022.

View on SEC.gov

AbbVie Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-045308

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.